Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.

about

Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.

Item

http://www.wikidata.org/entity/Q40122953

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of lumazine synthas ...... or polyvalent antigen display.

@en

type

Item

label

Evaluation of lumazine synthas ...... or polyvalent antigen display.

@en

prefLabel

Evaluation of lumazine synthas ...... or polyvalent antigen display.

@en

P1476

Evaluation of lumazine synthas ...... for polyvalent antigen display

@en

P2093

C Russell Middaugh

http://www.w3.org/2001/XMLSchema#string

David B Volkin

http://www.w3.org/2001/XMLSchema#string

Michael L Barta

http://www.w3.org/2001/XMLSchema#string

Prashant Kumar

http://www.w3.org/2001/XMLSchema#string

Wendy L Picking

http://www.w3.org/2001/XMLSchema#string

P2860

X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons

Crystallographic refinement of ricin to 2.5 A

Structural study and thermodynamic characterization of inhibitor binding to lumazine synthase fromBacillus anthracis

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

Versatile virus-like particle carrier for epitope based vaccines

Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy

Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.

Formaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses.

It's all about change: the antigen-driven initiation of B-cell receptor signaling

P304

2059-2072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRO.3243

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28736824

http://www.w3.org/2001/XMLSchema#string

P932

5606532

http://www.w3.org/2001/XMLSchema#string